CD19 CAR T cell therapy reshapes the host microbiota immune axis in autoimmune diseases
CD19 targeted CAR T cell therapy induces profound B cell depletion and clinical responses in autoimmune disease; however, whether it reshapes host microbio
CD19 targeted CAR T cell therapy induces profound B cell depletion and clinical responses in autoimmune disease; however, whether it reshapes host microbio